.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Healthtrust
Colorcon
Fuji
Argus Health
Harvard Business School
Deloitte
UBS
Daiichi Sankyo

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204516

« Back to Dashboard
NDA 204516 describes BRISDELLE, which is a drug marketed by Sebela Ireland Ltd and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge. Additional details are available on the BRISDELLE profile page.

The generic ingredient in BRISDELLE is paroxetine mesylate. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.

Summary for NDA: 204516

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 204516

Mechanism of ActionSerotonin Uptake Inhibitors

Suppliers and Packaging for NDA: 204516

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BRISDELLE
paroxetine mesylate
CAPSULE;ORAL 204516 NDA Sebela Pharmaceuticals Inc. 54766-907 54766-907-53 30 CAPSULE in 1 BLISTER PACK (54766-907-53)
BRISDELLE
paroxetine mesylate
CAPSULE;ORAL 204516 NDA Noven Therapeutics, LLC 68968-9075 68968-9075-3 30 CAPSULE in 1 BLISTER PACK (68968-9075-3)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 7.5MG BASE
Approval Date:Jun 28, 2013TE:RLD:Yes
Patent:5,874,447Patent Expiration:Jun 10, 2017Product Flag?Substance Flag?YDelist Request?
Patent:7,598,271Patent Expiration:May 4, 2025Product Flag?Substance Flag?YDelist Request?
Patent:8,658,663Patent Expiration:Apr 6, 2029Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE

Expired Orange Book Patents for NDA: 204516

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd
BRISDELLE
paroxetine mesylate
CAPSULE;ORAL204516-001Jun 28, 20135,874,447► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
QuintilesIMS
Harvard Business School
Argus Health
Healthtrust
Johnson and Johnson
Cerilliant
Cantor Fitzgerald
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot